ALEBUND PHARMACEUTICALS
Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions.
ALEBUND PHARMACEUTICALS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2018-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.alebund.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
259.96 M USD
Technology used in webpage:
SPF Xinnet DNS Dingfeng Xinhui
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
InxMed
InxMed is a clinical-stage biotech company dedicated to developing innovative, individualized medicines with international impact.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Visen Pharmaceuticals
Visen Pharmaceuticals is a biotech company focused on developing and commercializing innovative endocrine drugs.
Xellera Therapeutics
Xellera Therapeutics is a biotechnology company discovers and develops therapeutic and regenerative medicine for the treatment of diseases.
Current Employees Featured
Founder
Investors List
Octagon Capital Advisors
Octagon Capital Advisors investment in Series C - Alebund Pharmaceuticals
Guojin Capital
Guojin Capital investment in Series C - Alebund Pharmaceuticals
Quan Capital
Quan Capital investment in Series C - Alebund Pharmaceuticals
Verition Fund Management
Verition Fund Management investment in Series C - Alebund Pharmaceuticals
Lilly Asia Ventures
Lilly Asia Ventures investment in Series C - Alebund Pharmaceuticals
Jiangsu Dingxin Capital Management
Jiangsu Dingxin Capital Management investment in Series C - Alebund Pharmaceuticals
Yangzhou Longchuan Holdings
Yangzhou Longchuan Holdings investment in Series C - Alebund Pharmaceuticals
3H Health Investment
3H Health Investment investment in Series C - Alebund Pharmaceuticals
Morningside Ventures
Morningside Ventures investment in Series B - Alebund Pharmaceuticals
Sherpa Healthcare Partners
Sherpa Healthcare Partners investment in Series B - Alebund Pharmaceuticals
More informations about "Alebund Pharmaceuticals"
Leadership Team – Alebund
Over 15-year industry experience in Roche and other MNCs, focusing on organization development, talent management and compensation & benefits design in healthcare industrySee details»
Alebund Pharmaceuticals - Crunchbase Company …
Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.See details»
Alebund - 2025 Company Profile & Team - Tracxn
6 days ago Alebund is a series B company based in Shanghai (China), founded in 2018 by Jin Tian and Gavin Xia. It operates as a Developer of therapeutics for kidney diseases. Alebund …See details»
Alebund Pharmaceuticals - Org Chart, Teams, Culture & Jobs | The …
View Alebund Pharmaceuticals' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Alebund - VentureRadar
Alebund Pharmaceuticals is a Shangai, China-based biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic …See details»
Shanghai Alebund Pharmaceuticals Co., Ltd. (上海礼邦医药科技有 …
May 7, 2025 Alebund Pharmaceuticals, which focuses on treating chronic kidney disease, Kardigan, which is dedicated to developing precision therapies for cardiology, and Neko …See details»
Alebund Pharmaceuticals - Products, Competitors, Financials, …
Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions. Use the CB …See details»
Alebund Pharmaceuticals 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Alebund Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Alebund – Innovate Renal Therapeutics
Alebund is a clinical stage biopharmaceutical company focusing on novel therapies discovery and development primarily for kidney diseases and their complications, as well as other chronic …See details»
Alebund Pharmaceuticals Raises $60 million in Series B ... - BioSpace
Alebund Pharmaceuticals, a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions, announced that it …See details»
About Us – Alebund
Alebund is fully dedicated to providing high quality comprehensive solutions to the renal disease patients for the long-term, with our deep knowledge and expertise in all the areas necessary …See details»
Alebund Pharmaceuticals - Funding, Financials, Valuation & Investors
Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.See details»
Alebund | VentureRadar
Alebund is a clinical stage biopharmaceutical company focusing on novel therapies discovery and development primarily for kidney diseases and their complications, as well as other chronic …See details»
Alebund Pharmaceuticals - Contacts, Employees, Board Members, …
Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.See details»
Alebund Pharmaceuticals Closes Nearly RMB 200 Million Pre-C …
Shanghai, China, April 12th, 2023—Alebund Pharmaceuticals (“Alebund” or the “Company”) announced that it has closed its Pre-C round financing, with close to RMB 200 million. …See details»
Alebund Pharmaceuticals Raises $54.5 Million in Series B
Shanghai, China, Sep. 14, 2021 – Alebund Pharmaceuticals (“Alebund” or the “Company”), a biopharmaceutical company dedicated to developing innovative therapies for the treatment of …See details»
Alebund Announces Positive Topline Results from Pivotal Phase 3 …
10 hours ago Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for renal diseases …See details»
Alebund Pharmaceuticals Raises $54.5 Million in Series B
SHANGHAI, Sept. 13, 2021 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), a biopharmaceutical company dedicated to developing innovative therapies for …See details»
Pipelines and Focus – Alebund
The product under development by Alebund targets on renal hemodynamics and attenuates glomerular hyperfiltration, with a MOA that complements with ACEi/ARB and/or SGLT-2 …See details»
Alebund nets $29M in pre-C round to develop drugs for kidney …
Apr 14, 2023 Alebund Pharmaceuticals Ltd. raised ¥200 million (US$29 million) in a pre-C financing round to support the clinical trials of its candidates for kidney disease. It also secured …See details»